Comparison of first-line cetuximab and panitumumab plus doublet chemotherapies for left-sided colorectal cancer: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum.

Kawagoe R, Moriwaki T, Yamazaki K, Yukami H, Uetake H, Tsuda M, Suto T, Sugimoto N, Ojima H, Takii Y, Yasui H, Komoda M, Shimada Y, Tsuji A, Yamaguchi T, Sawada R, Shinozaki K, Otsu S, Shigeyasu K, Tsuchihashi K, Tamura T, Shiozawa M, Ueno H, Denda T, Ito T, Takashima A.

Open source

DOI: 10.1007/s10147-026-02999-z
Published: 2026-03-04
Container: Int J Clin Oncol
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10147-026-02999-z,
  title = {Comparison of first-line cetuximab and panitumumab plus doublet chemotherapies for left-sided colorectal cancer: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum.},
  author = {Kawagoe R and  Moriwaki T and  Yamazaki K and  Yukami H and  Uetake H and  Tsuda M and  Suto T and  Sugimoto N and  Ojima H and  Takii Y and  Yasui H and  Komoda M and  Shimada Y and  Tsuji A and  Yamaguchi T and  Sawada R and  Shinozaki K and  Otsu S and  Shigeyasu K and  Tsuchihashi K and  Tamura T and  Shiozawa M and  Ueno H and  Denda T and  Ito T and  Takashima A.},
  year = {2026},
  journal = {Int J Clin Oncol},
  doi = {10.1007/s10147-026-02999-z},
  url = {https://doi.org/10.1007/s10147-026-02999-z}
}

RIS

TY  - JOUR
TI  - Comparison of first-line cetuximab and panitumumab plus doublet chemotherapies for left-sided colorectal cancer: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum.
AU  - Kawagoe R
AU  -  Moriwaki T
AU  -  Yamazaki K
AU  -  Yukami H
AU  -  Uetake H
AU  -  Tsuda M
AU  -  Suto T
AU  -  Sugimoto N
AU  -  Ojima H
AU  -  Takii Y
AU  -  Yasui H
AU  -  Komoda M
AU  -  Shimada Y
AU  -  Tsuji A
AU  -  Yamaguchi T
AU  -  Sawada R
AU  -  Shinozaki K
AU  -  Otsu S
AU  -  Shigeyasu K
AU  -  Tsuchihashi K
AU  -  Tamura T
AU  -  Shiozawa M
AU  -  Ueno H
AU  -  Denda T
AU  -  Ito T
AU  -  Takashima A.
PY  - 2026
JO  - Int J Clin Oncol
DO  - 10.1007/s10147-026-02999-z
UR  - https://doi.org/10.1007/s10147-026-02999-z
ER  -

APA

R, K., T, M., K, Y., H, Y., H, U., M, T., T, S., N, S., H, O., Y, T., H, Y., M, K., Y, S., A, T., T, Y., R, S., K, S., S, O., K, S., K, T., T, T., M, S., H, U., T, D., T, I., & A., T. (2026). Comparison of first-line cetuximab and panitumumab plus doublet chemotherapies for left-sided colorectal cancer: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum.. Int J Clin Oncol. https://doi.org/10.1007/s10147-026-02999-z

Source records

europe-pmc · retrieved 2026-09-26T06:58:01.431Z